Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:1082-1084
Published online before print March 1, 2004, doi: 10.1161/01.CIR.0000121328.12536.07
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/9/1082    most recent
01.CIR.0000121328.12536.07v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilber, D. J.
Right arrow Articles by Moss, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilber, D. J.
Right arrow Articles by Moss, A. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
*Pacemakers and Implantable Defibrillators
Related Collections
Right arrow Ablation/ICD/surgery
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2004;109:1082-1084.)
© 2004 American Heart Association, Inc.


Brief Rapid Communications

Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction

David J. Wilber, MD; Wojciech Zareba, MD; W. Jackson Hall, PhD; Mary W. Brown, MS; Albert C. Lin, MD; Mark L. Andrews, BBS; Martin Burke, DO; Arthur J. Moss, MD

From the Cardiovascular Institute, Loyola University Medical Center, Maywood, Ill (D.J.W., A.C.L., M.B.), and the Cardiology Unit (W.Z., M.W.B., M.L.A., A.J.M.) and Department of Biostatistics (W.J.H.), University of Rochester Medical Center, Rochester, NY.

Correspondence to David J. Wilber, MD, Loyola Cardiovascular Institute, Bldg 110, Room 6232, Loyola University Medical Center, 2160 S First Ave, Maywood, IL 60153. E-mail dwilber{at}lumc.edu

Received October 25, 2003; revision received January 6, 2004; accepted January 16, 2004.

Background— Prophylactic implantable defibrillators (ICDs) improve survival in patients with impaired ventricular function after myocardial infarction (MI), but it is uncertain whether mortality risk and survival benefit depend on the elapsed time from MI.

Methods and Results— The Multicenter Automatic Defibrillator Implantation Trial II examined the impact of ICDs on survival in post-MI patients with ejection fractions <=30%. In 1159 patients, mean time from most recent MI to enrollment was 81±78 months. Patients were randomized to an ICD (n=699) or conventional care (n=460) in a 3:2 ratio. Mortality rates (deaths per 100 person-years of follow-up) in both treatment groups were analyzed by time from MI divided into quartiles (<18, 18 to 59, 60 to 119, and >=120 months). In conventional care patients, these rates increased as time from MI increased (7.8%, 8.4%, 11.6%, 14.0%; P=0.03). Mortality rates in ICD patients were consistently lower in each quartile and showed minimal increase over time (7.2%, 4.9%, 8.2%, 9.0%; P=0.19). Covariate-adjusted hazard ratios for risk of death associated with ICD therapy were 0.97 (95% CI, 0.51 to 1.81; P=0.92) for recent MI (<18 months) and 0.55 (95% CI, 0.39 to 0.78; P=0.001) for remote MI (>=18 months).

Conclusions— Mortality risk in patients with ejection fractions <=30% increases as a function of time from MI. The survival benefit associated with ICDs appears to be greater for remote MI and remains substantial for up to >=15 years after MI.


Key Words: defibrillation • myocardial infarction • survival


Related Article:

Primary Prevention of Sudden Cardiac Death: The Time of Your Life
Eric N. Prystowsky
Circulation 2004 109: 1073-1075. [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
Circulation, September 30, 2008; 118(14): 1497 - 1518.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. V. Exner, K. M. Kavanagh, M. P. Slawnych, L. B. Mitchell, D. Ramadan, S. G. Aggarwal, C. Noullett, A. Van Schaik, R. T. Mitchell, M. A. Shibata, et al.
Noninvasive Risk Assessment Early After a Myocardial Infarction: The REFINE Study
J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2275 - 2284.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
S. K H Lam and A. Owen
Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials
BMJ, November 3, 2007; 335(7626): 925 - 925.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. Santini, C. Lavalle, and R. P. Ricci
Primary and secondary prevention of sudden cardiac death: who should get an ICD?
Heart, November 1, 2007; 93(11): 1478 - 1483.
[Full Text] [PDF]


Home page
CirculationHome page
R. Passman and A. Kadish
Sudden Death Prevention With Implantable Devices
Circulation, July 31, 2007; 116(5): 561 - 571.
[Full Text] [PDF]


Home page
CirculationHome page
T. J. Bunch, S. H. Hohnloser, and B. J. Gersh
Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators
Circulation, May 8, 2007; 115(18): 2451 - 2457.
[Full Text] [PDF]


Home page
JAMAHome page
P. J. Zimetbaum
A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator
JAMA, May 2, 2007; 297(17): 1909 - 1916.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Schober and B. C. Knollmann
Exercise After Myocardial Infarction Improves Contractility and Decreases Myofilament Ca2+ Sensitivity
Circ. Res., April 13, 2007; 100(7): 937 - 939.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, C. A. Baessler, A. B. Curtis, N.A. M. Estes III, B. J. Gersh, B. Grubb, and L. B. Mitchell
Addendum to "Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/ Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology" Public Safety Issues in Patients With Implantable Defibrillators A Scientific Statement From the American Heart Association and the Heart Rhythm Society
Circulation, March 6, 2007; 115(9): 1170 - 1176.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. A. Saxon, M. R. Bristow, J. Boehmer, S. Krueger, D. A. Kass, T. De Marco, P. Carson, L. DiCarlo, A. M. Feldman, E. Galle, et al.
Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
Circulation, December 19, 2006; 114(25): 2766 - 2772.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al.
Navigating the Crossroads of Coronary Artery Disease and Heart Failure
Circulation, September 12, 2006; 114(11): 1202 - 1213.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
EuropaceHome page
S. Nisam and G. Breithardt
Lessons learned from neutral ICD trials
Europace, June 1, 2006; 8(6): 393 - 397.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Pascale, P. Taffe, C. Regamey, L. Kappenberger, and M. Fromer
Reduced Ejection Fraction After Myocardial Infarction: Is It Sufficient To Justify Implantation of a Defibrillator?
Chest, October 1, 2005; 128(4): 2626 - 2632.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Bogun, S. Krishnan, M. Siddiqui, E. Good, J. E. Marine, C. Schuger, H. Oral, A. Chugh, F. Pelosi, and F. Morady
Electrogram Characteristics in Postinfarction Ventricular Tachycardia: Effect of Infarct Age
J. Am. Coll. Cardiol., August 16, 2005; 46(4): 667 - 674.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator?
Circulation, May 17, 2005; 111(19): 2537 - 2549.
[Full Text] [PDF]


Home page
NEJMHome page
M. B. McClellan and S. R. Tunis
Medicare Coverage of ICDs
N. Engl. J. Med., January 20, 2005; 352(3): 222 - 224.
[Full Text] [PDF]


Home page
NEJMHome page
S. H. Hohnloser, K. H. Kuck, P. Dorian, R. S. Roberts, J. R. Hampton, R. Hatala, E. Fain, M. Gent, S. J. Connolly, and the DINAMIT Investigators
Prophylactic Use of an Implantable Cardioverter-Defibrillator after Acute Myocardial Infarction
N. Engl. J. Med., December 9, 2004; 351(24): 2481 - 2488.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. M. Gillis
Prophylactic Implantable Cardioverter-Defibrillators after Myocardial Infarction -- Not for Everyone
N. Engl. J. Med., December 9, 2004; 351(24): 2540 - 2542.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. V. Huikuri, J. M. Tapanainen, and T. H. Makikallio
Reply
J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1529 - 1529.
[Full Text] [PDF]


Home page
CirculationHome page
P. Pascale, L. Kappenberger, M. Fromer, D. J. Wilber, A. C. Lin, M. Burke, W. Zareba, M. W. Brown, M. L. Andrews, A. J. Moss, et al.
Mortality Risk and Defibrillator Benefit After Myocardial Infarction * Response
Circulation, September 14, 2004; 110(11): e304 - e304.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
ICD Implantation After MI: Does Timing Matter?
Journal Watch Cardiology, May 21, 2004; 2004(521): 5 - 5.
[Full Text]


Home page
CirculationHome page
E. N. Prystowsky
Primary Prevention of Sudden Cardiac Death: The Time of Your Life
Circulation, March 9, 2004; 109(9): 1073 - 1075.
[Full Text] [PDF]